Research Article
Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients
Table 2
Frequency of hepatobiliary manifestations and concomitant liver disease in UC and CD patients.
| | Hepatobiliary manifestations | Ulcerative colitis
N=165 | Crohn’s disease
N=141 | Total
N =306 |
| | Steatosis/steatohepatitis, n (%) | 11 (6.7) | 11 (7.8) | 22 (7.2) | | Cholelithiasis, n (%) | 9 (5.5) | 11 (7.8) | 20 (6.5) | | PSC, n (%) | 6 (3.6) | 4 (2.8) | 10 (3.3) | | Drug hepatotoxicity, n (%) | 3 (1.8) | 3 (2.1) | 6 (2.0) | | Hepatitis B, n (%) | 1 (0.6) | 1 (0.7) | 1 (0.7) | | Hepatitis C, n (%) | 1 (0.6) | 1 (0.7) | 2 (0.7) | | Hepatic fibrosis, n (%) | 0.6(1) | - | 1 (0.3) | | HAI, n (%) | - | 1 (0.7) | 1 (0.3) | | Alcoholic liver disease, n (%) | - | 1 (0.7) | 1 (0.3) |
|
|
PSC: Primary sclerosing cholangitis; HAI: Autoimmune hepatitis.
Note: In some cases, the same patient presented with more than one manifestation.
|
